ArticleFrontiers in oncology2026

Assessing the impact of phosphodiesterase 5 inhibitors on survival in men after treatment for rectal cancer.

Myroslav Lutsyk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.